Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion - Nyflot, M J; Kruser, T J; Traynor, A M (Int J Radiat Oncol Biol Phys, 2015)
et al.